title: Continuing education case study quiz.
abstract: Goal- The goal of this program is to educate pharmacists about the use of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (df) combination tablet for the treatment of HIV infection. Objectives-At the completion of this program, the reader will be able to:Describe the pharmacology and pharmacokinetics of elvitegravir/cobicistat/emtricitabine/tenofovir df combination.Discuss the risks associated with the use of elvitegravir/cobicistat/emtricitabine/tenofovir df combination.Discuss the potential benefit of elvitegravir/cobicistat/emtricitabine/tenofovir df combination for an individual patient.Apply the information on the use of elvitegravir/cobicistat/emtricitabine/tenofovir df combination to a case study.
keywords: HIV; Stribild; cobicistat; elvitegravir; emtricitabine; new drugs; obesity; phentermine; tenofovir disoproxil fumarate; topiramate